One of the largest companies involved in next-generation sequencing technology is buying a rival that manufactures genomic analysis systems.
{iframe}https://medcitynews.com/2018/11/illumina-to-buy-pacific-biosciences-for-1-2-billion/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=67207174&_hsenc=p2ANqtz-_gIeks2fzLQ8FRpx7d9L7XPxOmP2Q5QLZWR8mmTzbqCWoL_UP-nj0JiZy3sCESBSAWQ74mUkXOD57st0uCJF571TWm1A&_hsmi=67207174{/iframe}